Watanabe Todd

Watanabe Todd is listed in filings as See Remarks at Arcutis Biotherapeutics, Inc. - Common stock. This profile follows SEC Form 4 activity through May 6, 2026, including sale activity. Recent filings connect the profile to Arcutis Biotherapeutics, Inc. - Common stock (ARQT). The current snapshot covers public activity from Aug 5, 2025 to May 6, 2026. Reported amounts are shown as $74.9K to $27.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.